探讨双硫化相关特征在胆管癌免疫微环境、预后和治疗策略中

这项研究将 DRG 与 CCA 预后和免疫动力学联系起来，提供了强大的四基因预后工具，并将 CD109 和 EFNB2 确定为潜在的治疗靶点。二硫化症成为 CCA 精准医学的一个有前途的焦点This study correlates DRG with the prognosis and immune dynamics of CCA, develops a robust four-gene prognostic tool, identifies CD109 and EFNB2 as potential therapeutic targets, and establishes disulfidptosis as a promising focus for precision medicine in CCA.